Leading drugmaker, May & Baker Nigeria Plc, has reported an 84% rise in its Profit After-Tax (PAT) for Full Year 2019 amidst a revenue crunch that...
May & Baker Nigeria Plc has signed an agreement with the National Institute for Pharmaceutical Research and Development (NIPRD) for commercial production of anti sickle cell...
Investors in May & Baker Nigeria Plc received a major boost on Wednesday with the inauguration of the board of the group’s domestic vaccine-producing company– Biovaccines...
